A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system ... Blood Proteins May Help to Track the Pathological Progression of Lewy's Body Disease July 31, 2024 — New research ...

There are a total of 93 products in Phase I-III development for PD treatment. The Parkinson’s disease (PD) therapeutic ...

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients with Parkinson's disease-related dementia and Lewy body dementia.

The research team suggests that the treatment can help address very early stages of a condition such as Alzheimer’s or ...

Combining the checkpoint inhibitor atezolizumab with targeted therapy led to improvements in overall survival in patients with anaplastic thyroid cancer.

The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant ...